Urinary Metabotyping of Bladder Cancer Using Two-Dimensional Gas Chromatography Time-of-Flight Mass Spectrometry
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Cystoscopy is the gold standard clinical diagnosis of human bladder cancer (BC). As cystoscopy is expensive and invasive, it compromises patients' compliance toward surveillance screening and challenges the detection of recurrent BC. Therefore, the development of a noninvasive method for the diagnosis and surveillance of BC and the elucidation of BC progression become pertinent. In this study, urine samples from 38 BC patients and 61 non-BC controls were subjected to urinary metabotyping using two-dimensional gas chromatography time-of-flight mass spectrometry (GC×GC-TOFMS). Subsequent to data preprocessing and chemometric analysis, the orthogonal partial least-squares discriminant analysis (OPLS-DA, R2X=0.278, R2Y=0.904 and Q2Y (cumulative)=0.398) model was validated using permutation tests and receiver operating characteristic (ROC) analysis. Marker metabolites were further screened from the OPLS-DA model using statistical tests. GC×GC-TOFMS urinary metabotyping demonstrated 100% specificity and 71% sensitivity in detecting BC, while 100% specificity and 46% sensitivity were observed via cytology. In addition, the model revealed 46 metabolites that characterize human BC. Among the perturbed metabolic pathways, our clinical finding on the alteration of the tryptophan-quinolinic metabolic axis in BC suggested the potential roles of kynurenine in the malignancy and therapy of BC. In conclusion, global urinary metabotyping holds potential for the noninvasive diagnosis and surveillance of BC in clinics. In addition, perturbed metabolic pathways gleaned from urinary metabotyping shed new and established insights on the biology of human BC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, a study of urinary metabolites of bladder cancer cases compared with non-bladder cancer controls found significant perturbations of the kynurenine pathway, with tryptophan levels consistently lower in cases (Pasikanti et al., 2013).”
From Effects of exposure to water disinfection by-products in a swimming pool: A metabolome-wide association study (2018) · cites this paper as Pasikanti et al., 2013
Citations
Cites
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Nicholson, J. K., Lindon, J. C., & Holmes, E. (1999) · Xenobiotica · doi:10.1080/004982599238047 · Cited by 3,895
Metabolomics—the link between genotypes and phenotypes
Fiehn, O. (2002) · Plant Molecular Biology · doi:10.1023/a:1013713905833 · Cited by 3,445
HMDB: the Human Metabolome Database
Wishart, D. S., Tzur, D., Knox, C., Eisner, R., Guo, A. C., Young, N., Cheng, D., Jewell, K., Arndt, D., Sawhney, S., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl923 · Cited by 3,231
Metabolomics — the link between genotypes and phenotypes
Fiehn, O. (2002) · Functional Genomics · doi:10.1007/978-94-010-0448-0_11 · Cited by 3,167
Projections of the cost of cancer care in the United States: 2010–2020
Mariotto, A. B., Robin Yabroff, K., Shao, Y., Feuer, E. J., & Brown, M. L. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq495 · Cited by 2,657
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Sreekumar, A., Poisson, L. M., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R. J., Li, Y., et al. (2009) · Nature · doi:10.1038/nature07762 · Cited by 2,234
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Opitz, C. A., Litzenburger, U. M., Sahm, F., Ott, M., Tritschler, I., Trump, S., Schumacher, T., Jestaedt, L., Schrenk, D., Weller, M., et al. (2011) · Nature · doi:10.1038/nature10491 · Cited by 1,898
Epstein, J. I., Amin, M. B., Reuter, V. R., & Mostofi, F. K. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199812000-00001 · Cited by 1,578
GMD@CSB.DB: the Golm Metabolome Database
Kopka, J., Schauer, N., Krueger, S., Birkemeyer, C., Usadel, B., Bergmuller, E., Dormann, P., Weckwerth, W., Gibon, Y., Stitt, M., et al. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti236 · Cited by 1,382
Research works printed but not linked: 3
- Onuki T., 2007, Hinyokika Kiyo, 53, 449
- Panichi S., 1999, Ann. Ital. Chir., 70, 937
- Nyholm K. K., 1975, Biomedicine, 22, 509
Cited by
Items 101–114 of 114
Data from Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum
Penney, K. L., Tyekucheva, S., Rosenthal, J., Fandy, H. E., Carelli, R., Borgstein, S., Zadra, G., Fanelli, G. N., Stefanizzi, L., Giunchi, F., et al. (2023) · doi:10.1158/1541-7786.c.6545205
Supplementary Figure 2 from Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum
Penney, K. L., Tyekucheva, S., Rosenthal, J., Fandy, H. E., Carelli, R., Borgstein, S., Zadra, G., Fanelli, G. N., Stefanizzi, L., Giunchi, F., et al. (2023) · doi:10.1158/1541-7786.22526775.v1
Supplementary Figure 1 from Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum
Penney, K. L., Tyekucheva, S., Rosenthal, J., Fandy, H. E., Carelli, R., Borgstein, S., Zadra, G., Fanelli, G. N., Stefanizzi, L., Giunchi, F., et al. (2023) · doi:10.1158/1541-7786.22526778
Data from Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum
Penney, K. L., Tyekucheva, S., Rosenthal, J., Fandy, H. E., Carelli, R., Borgstein, S., Zadra, G., Fanelli, G. N., Stefanizzi, L., Giunchi, F., et al. (2023) · doi:10.1158/1541-7786.c.6545205.v1
An, R., Yu, H., Wang, Y., Lü, J., Gao, Y., Xie, X., & Zhang, J. (2022) · Figshare · doi:10.6084/m9.figshare.20508668
Su, X., Dong, C., Liao, W., & Liu, W. (2024) · Figshare · doi:10.6084/m9.figshare.26613410
Su, X., Dong, C., Liao, W., & Liu, W. (2024) · Figshare · doi:10.6084/m9.figshare.26613404
Su, X., Dong, C., Liao, W., & Liu, W. (2024) · Figshare · doi:10.6084/m9.figshare.26613407
An, R., Yu, H., Wang, Y., Lu, J., Gao, Y., Xie, X., & Zhang, J. (2022) · Figshare · doi:10.6084/m9.figshare.20508665
Su, X., Dong, C., Liao, W., & Liu, W. (2024) · Figshare · doi:10.6084/m9.figshare.26613401
Urinary metabolomics identifies lactate as a biomarker for bladder cancer detection and progression
Carapito, Â., Sousa, T. V., Teixeira-Marques, A. R., Henrique, R., Jerónimo, C., Roque, A. C. A., Carvalho, F., Pinto, J., & de Pinho, P. G. (2026) · Molecular Omics · doi:10.1093/molecular-omics/aaiag004
Kumar, L., Gupta, N., Kural, S., Verma, A., Thakur, A., Agarwal, S., Gupta, P., Tiwari, H., Singh, S., Kumari, V., et al. (2026) · ChemistrySelect · doi:10.1002/slct.202506172
Frolova, A., Vokuev, M., Ikhalainen, Y., Prosuntsova, D. S., & Rodin, I. A. (2026) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-026-06678-w
Carapito, Â., Amaro, F., Roque, A. C. A., Carvalho, F. D., Pinto, J., & de Pinho, P. G. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27208983
“Despite this heterogeneity, investigations incorporating both internal and external validation [20–23, For BC detection (BC vs. cancer-free individuals, Table 2), metabolites that were recurrently identified across these panels included intermediates of energy metabolism (e.g., lactate [20,24],…”
Influential
Metadata
- Authors
- Pasikanti, K. K., Esuvaranathan, K., Hong, Y., Ho, P. C., Mahendran, R., Raman Nee Mani, L., Chiong, E., & Chan, E. C. Y.
- Affiliations
- National University of Singapore (SG)
- National University Health System (SG)
- Department of Surgery, National University Health System, 5 Lower Kent Ridge Road, Singapore 119074
- Corresponding author
- Esuvaranathan, Kesavan
- Chan, Eric Chun Yong
- ORCID
- Venue
- Journal of Proteome Research
- Publisher
- American Chemical Society (ACS)
- Published
- 2013-08-07
- Volume
- 12
- Issue
- 9
- Pages
- 3865-3873
- ISSN
- 1535-3893 (ISSN-L)
- 1535-3907
- OpenAlex
- W2327028950
- Cited by
- 113
- References
- 49
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 12 · 2023: 8 · 2022: 14 · 2021: 14 · 2020: 10 · 2019: 10 · 2018: 12 · 2017: 8 · 2016: 6 · 2015: 6 · 2014: 6 · 2013: 1
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Proteome Research (publishedVersion)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Physical Sciences › Engineering › Biomedical Engineering › Advanced Chemical Sensor Technologies
- Health Sciences › Medicine › Surgery › Bladder and Urothelial Cancer Treatments
- Keywords
- bladder cancer, non-invasive diagnosis, cancer surveillance, tryptophan metabolism, kynurenine, quinolinic acid, biomarkers, cystoscopy alternative
- MeSH terms
- Aged, Urinary Bladder Neoplasms, Creatinine, Female, Humans, Male, Gas Chromatography-Mass Spectrometry, Middle Aged, Tryptophan, Biomarkers, Tumor, Case-Control Studies, Metabolomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.